These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16462046)

  • 1. Potent analgesic and anti-inflammatory activities of 1-furan-2-yl-3-pyridin-2-yl-propenone with gastric ulcer sparing effect.
    Lee ES; Park BC; Paek SH; Lee YS; Basnet A; Jin DQ; Choi HG; Yong CS; Kim JA
    Biol Pharm Bull; 2006 Feb; 29(2):361-4. PubMed ID: 16462046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of 1-furan-2-yl-3-pyridine-2-yl-propenone on pharmacokinetic parameters of theophylline.
    Shanmugam S; Lee ES; Lee SK; Jeon TW; Yong CS; Yoo BK
    Biol Pharm Bull; 2006 Jun; 29(6):1282-5. PubMed ID: 16755035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory effect and low ulcerogenic activity of etodolac, a cyclooxygenase-2 selective non-steroidal anti-inflammatory drug, on adjuvant-induced arthritis in rats.
    Tachibana M; Inoue N; Yoshida E; Matsui M; Ukai Y; Yano J
    Pharmacology; 2003 Jun; 68(2):96-104. PubMed ID: 12711837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of 1-furan-2-yl-3-pyridine-2-yl-propenone on pharmacokinetic parameters of warfarin.
    Shanmugam S; Lee ES; Jeong TC; Yong CS; Choi HG; Woo JS; Yoo BK
    Arch Pharm Res; 2007 Jul; 30(7):898-904. PubMed ID: 17703744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.
    Takeuchi K; Suzuki K; Yamamoto H; Araki H; Mizoguchi H; Ukawa H
    J Physiol Pharmacol; 1998 Dec; 49(4):501-13. PubMed ID: 10069692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the Nrf2-antioxidant system by a novel cyclooxygenase-2 inhibitor furan-2-yl-3-pyridin-2-yl-propenone: implication in anti-inflammatory function by Nrf2 activator.
    Manandhar S; You A; Lee ES; Kim JA; Kwak MK
    J Pharm Pharmacol; 2008 Jul; 60(7):879-87. PubMed ID: 18549674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-angiogenic effects of 1-furan-2-yl-3-pyridin-2-yl-propenone are mediated through the suppression of both VEGF production and VEGF-induced signaling.
    Park BC; Park SY; Lee JS; Mousa SA; Kim JT; Kwak MK; Kang KW; Lee ES; Choi HG; Yong CS; Kim JA
    Vascul Pharmacol; 2009; 50(3-4):123-31. PubMed ID: 19068239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
    Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
    Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory effects and gastrointestinal safety of NNU-hdpa, a novel dual COX/5-LOX inhibitor.
    Xu GL; Liu F; Ao GZ; He SY; Ju M; Zhao Y; Xue T
    Eur J Pharmacol; 2009 Jun; 611(1-3):100-6. PubMed ID: 19345206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survivin: a novel target for indomethacin-induced gastric injury.
    Chiou SK; Tanigawa T; Akahoshi T; Abdelkarim B; Jones MK; Tarnawski AS
    Gastroenterology; 2005 Jan; 128(1):63-73. PubMed ID: 15633124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethanesulfohydroxamic acid ester prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs): synthesis, nitric oxide and nitroxyl release, cyclooxygenase inhibition, anti-inflammatory, and ulcerogenicity index studies.
    Huang Z; Velázquez CA; Abdellatif KR; Chowdhury MA; Reisz JA; DuMond JF; King SB; Knaus EE
    J Med Chem; 2011 Mar; 54(5):1356-64. PubMed ID: 21280601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing.
    Colucci R; Antonioli L; Bernardini N; Ippolito C; Segnani C; Awwad O; Tuccori M; Blandizzi C; Scarpignato C; Fornai M
    J Pharmacol Exp Ther; 2012 Jul; 342(1):140-9. PubMed ID: 22495067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, molecular docking and biological evaluation of some newer 2-substituted-4-(benzo[d][1,3]dioxol-5-yl)-6-phenylpyridazin-3(2H)-ones as potential anti-inflammatory and analgesic agents.
    Singh J; Saini V; Kumar A; Bansal R
    Bioorg Chem; 2017 Apr; 71():201-210. PubMed ID: 28236449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric acid is the key modulator in the pathogenesis of non-steroidal anti-inflammatory drug-induced ulceration in rats.
    Zinkievich JM; George S; Jha S; Nandi J; Levine RA
    Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):654-61. PubMed ID: 20082628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological evaluation of 2-(4-amino-phenyl)-3-(3,5-dihydroxylphenyl) propenoic acid.
    Xu GL; Liu F; Zhao Y; Ao GZ; Xi L; Ju M; Xue T
    Basic Clin Pharmacol Toxicol; 2009 Nov; 105(5):350-6. PubMed ID: 19744157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of 1-furan-2-yl-3-pyridin-2-yl-propenone, an anti-inflammatory propenone compound, by high performance liquid chromatography with ultraviolet spectrometry.
    Lee SK; Jeon TW; Basnet A; Lee ES; Jeong TC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 837(1-2):108-11. PubMed ID: 16687255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of novel anti-inflammatory compounds on healing of acetic acid-induced gastric ulcer in rats.
    Lesch CA; Gilbertsen RB; Song Y; Dyer RD; Schrier D; Kraus ER; Sanchez B; Guglietta A
    J Pharmacol Exp Ther; 1998 Oct; 287(1):301-6. PubMed ID: 9765350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemopreventive effects of Furan-2-yl-3-pyridin-2-yl-propenone against 7,12-dimethylbenz[a]anthracene-inducible genotoxicity.
    Hwang YP; Han EH; Choi JH; Kim HG; Lee KJ; Jeong TC; Lee ES; Jeong HG
    Toxicol Appl Pharmacol; 2008 May; 228(3):343-50. PubMed ID: 18255114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.